Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion type Assertion NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_head.
- NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion description "[We suggest that combinations of AURKA antagonists and EGFR inhibitors may be effective in clinical trials targeting mutant EGFR NSCLCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_provenance.
- NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion evidence source_evidence_literature NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_provenance.
- NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion SIO_000772 25634113 NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_provenance.
- NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion wasDerivedFrom befree-2016 NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_provenance.
- NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_assertion wasGeneratedBy ECO_0000203 NP1259453.RA7Ww68IAlUo875VT--qhTGRNn8H4aFp8SnjXl8hPvq24130_provenance.